Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
6.64
+0.26 (4.16%)
At close: Jul 14, 2025, 4:00 PM
6.62
-0.01 (-0.23%)
After-hours: Jul 14, 2025, 4:00 PM EDT
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $374.44 million as of July 14, 2025. Its market cap has decreased by -24.40% in one year.
Market Cap
374.44M
Enterprise Value
77.39M
1-Year Change
-24.40%
Ranking
Category
Stock Price
$6.64
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $374.44M, an increase of 108.02%. That is a compound annual growth rate of 7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 359.50M | -28.74% |
| Dec 31, 2024 | 504.50M | 80.95% |
| Dec 29, 2023 | 278.80M | 11.30% |
| Dec 30, 2022 | 250.50M | 257.35% |
| Dec 31, 2021 | 70.10M | 63.02% |
| Dec 31, 2020 | 43.00M | -38.31% |
| Dec 31, 2019 | 69.70M | 124.84% |
| Dec 31, 2018 | 31.00M | -9.88% |
| Dec 29, 2017 | 34.40M | -48.89% |
| Dec 30, 2016 | 67.30M | -44.52% |
| Dec 31, 2015 | 121.30M | -32.61% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |